Search Results (3,682)

Introduction: Vitamin B12 (VB12), particularly its active form methylcobalamin (MeB12), contributes to neuromuscular function and energy metabolism, which may be relevant for sports performance. However, evidence on the acute effects of MeB12 supplementation in athletes remains limited. Objective: To evaluate the effects of short-term (3-day) MeB12 supplementation on anaerobic and cognitive performance in amateur cyclists. Methods: A randomized, triple-blind, placebo-controlled crossover clinical trial was conducted in 18 amateur cyclists. Participants received formulations containing MeB12 (1 mg/day; MecobalActive^®, HTBA, Murcia, Spain) or placebo for three consecutive days. Anaerobic performance was assessed using a repeated Wingate protocol, and cognitive performance was evaluated using a light-based mental agility/reaction test system. Biochemical analyses included serum VB12 concentrations. Primary outcomes included peak power output (absolute and relative), fatigue index across repeated sprints, and cognitive response time. Results: Compared with placebo, MeB12 supplementation was associated with higher peak power output, with increases in absolute maximal power (PMAX: +4.1%, p = 0.016) and relative maximal power (PMAXREL: +4.4%, p = 0.013). MeB12 supplementation was associated with a smaller decline in performance across repeated sprints, with a smaller drop in fatigue index from the first to the fifth sprint (p = 0.012). Pre-exercise cognitive performance improved, with a shorter total reaction test time (−4.9%, p < 0.001) versus placebo. Serum VB12 concentrations increased by 16.8% following MeB12 supplementation. Conclusions: A brief, 3-day intervention with methylcobalamin (1 mg/day) was associated with positive changes, when compared with placebo, in selected markers of anaerobic performance (peak power and fatigue-related decline) and pre-exercise cognitive performance in recreationally trained amateur cyclists, suggesting a possible involvement of peripheral and central mechanisms. Full article

Background/Objectives: Healthy longevity depends on not only lifespan but also the maintenance of physiological, metabolic, physical, and cognitive functions throughout aging. Identifying early determinants of health is crucial for preventing age-related decline. This narrative review aims to synthesize current evidence on how diet and specific nutrients relate to these early risk factors and indicators of healthy longevity. Methods: A review was performed to identify the links between dietary factors, energy balance, and gut microbiota composition and normal body weight; blood cholesterol, pressure, and glucose; healthy sleep; an active lifestyle; and normal physical function and cognitive performance. Particular attention was given to Mediterranean and other plant-based dietary models as sources of key nutrients. Evidence from observational studies, randomized controlled trials, and meta-analyses was considered. Results: Across all markers, dietary quality and nutrient adequacy emerged as consistent determinants of health outcomes. Key nutrients were associated with favorable cardiometabolic, cognitive, and musculoskeletal functions, such as omega-3 fatty acids, fiber, vitamins D and B, minerals like magnesium and potassium, and polyphenols. Common nutrition gaps included insufficient intake of fiber, unsaturated fats, and micronutrients, which was often linked to a shift toward less plant-based diets. Gut microbiota diversity may mediate several of these associations, influencing metabolism, inflammation, sleep quality, and cognitive performance, although inter-individual variability and causal pathways remain incompletely understood. Conclusions: An integrated dietary approach emphasizing the consumption of whole and plant-rich foods, with moderate amounts of animal foods, supports multiple early markers, risk factors, and indicators of healthy longevity. The modulation of the gut microbiota through plant-based diets and fermented foods represents a promising strategy for maintaining health across aging trajectories. Full article

Nicotinamide mononucleotide (NMN) plays vital physiological roles as a vitamin B derivative, with nicotinamide riboside kinase (NRK) serving as a key enzyme for its efficient and environmentally friendly synthesis. In this study, semi-rational design was employed to modify the Hi-NRK enzyme at the molecular level, leading to the identification of a critical mutant, Hi-NRK^G8S. This variant exhibited a twofold increase in enzymatic activity and significantly enhanced thermal stability, extending its half-life at 40 °C from 4 to 8 h. By optimizing reaction conditions, NMN yield reached 94.17% at a nicotinamide riboside (NR) substrate concentration of 50 g/L. Further addition of adenylate kinase (ADK) to facilitate ATP recycling increased the yield to 97.24% at 75 g/L NR. This study establishes a foundation for industrial-scale, efficient, and green NMN production. Full article

Hypertension remains a leading cause of global morbidity and mortality, and angiotensin-converting enzyme (ACE) represents a central therapeutic target within the renin–angiotensin–aldosterone system. Marine microalgae, particularly Phaeodactylum tricornutum, provide an underexplored reservoir of structurally diverse metabolites with potential cardiovascular relevance. In this in silico study, we characterized metabolites putatively annotated by UPLC-ESI-HRMS and evaluated their predicted ACE inhibitory potential. We performed molecular docking with AutoDock 4 and assessed pharmacokinetic and toxicological properties using the SwissADME, PASS, and ProTox platforms. Several metabolites showed favorable binding orientations within the ACE catalytic pocket, including interactions with key residues and proximity to the zinc-binding motif. Lehualide G, Val–Asn–Pro, tanariflavanone B, hydroxyterbinafine, and anhydro-vitamin A exhibited the most favorable docking profiles. PASS predictions indicated vascular-related bioactivity signals for selected compounds, whereas ADMET modeling revealed heterogeneous but classifiable pharmacokinetic and safety characteristics. The convergence of predicted binding compatibility, bioactivity signals, and stratified safety margins supports P. tricornutum as a promising source of candidate molecules for further experimental validation in antihypertensive research. Full article

Soil acidification and low nutrient availability in acidic red soils are major constraints on pecan (Carya illinoinensis) productivity and fruit quality. However, the integrated effects of quicklime and biochar application in pecan orchards on acidic red soils remain poorly understood. In this context, a field experiment was conducted in an 8-year-old pecan orchard in an acidic red soil region to evaluate the effects of sole and combined applications of biochar and quicklime at different ratios on soil properties, fruit yield, and quality. The results showed that the combined application of biochar and quicklime showed greater benefits for soil fertility, fruit yield, and kernel quality than single-amendment treatments. The combined treatments significantly increased soil pH by 0.47–2.15 units relative to the control and markedly improved soil nutrient status. After 12 months of application, SOM contents under L1B–L3B were 20.8–23.2% higher than those under the corresponding quicklime-only treatments, reaching 37.57–43.37 g·kg⁻¹. The combined treatments also maintained higher total nitrogen, total phosphorus, and available potassium levels than the corresponding quicklime-only treatments, with TN under L1B–L3B reaching 1.65–1.78 g·kg⁻¹, representing a 126.0–166.7% increase over their respective quicklime-only treatments. The combined treatments also generally enhanced soil biological activity and improved fruit yield and quality. Their effects on fruit traits varied with application ratio: the low-dose treatment (L1B, 2 kg biochar + 1 kg quicklime) was more effective in improving physical traits such as dry kernel weight and kernel percentage; the medium-dose treatment (L2B, 2 kg biochar + 1.5 kg quicklime) produced the highest single-tree yield, reaching 26.80 kg·tree⁻¹, which was 24.25% higher than the control and significantly higher than all single-amendment treatments (23.43–25.07 kg·tree⁻¹); and the high-dose treatment (L3B, 2 kg biochar + 2 kg quicklime) was more favorable for improving nutritional quality, increasing amino acid and vitamin E contents to 1267.01 μg·kg⁻¹ and 153.22 μg·g⁻¹, respectively, which were 45.41–91.90% and 5.02–78.77% higher than those under the single-amendment treatments. Overall, the combined application of biochar and quicklime effectively alleviated soil acidification, improved soil fertility, and promoted higher fruit yield and quality, providing a scientific basis for the efficient, high-quality, and sustainable development of pecan orchards in acidic red soil regions. Full article

Plant extracts and microbiological supernatants were subjected to qualitative and compositional analyses to characterize their bioactive profiles and assess their potential agricultural applications. The garlic (Allium sativum) extract was rich in allicin and selected free amino acids, contained betulin as the dominant triterpene, and displayed a favorable elemental profile with high levels of potassium, phosphorus, sulfur, calcium, and magnesium, with no detectable heavy metals. Detectable amounts of B-group vitamins and vitamin E isoforms were also identified. Qualitative phytochemical screening confirmed the presence of saponins and flavonoids in the garlic extract. The Jerusalem artichoke (Helianthus tuberosus) extract exhibited a significantly higher total phenolic content compared to the garlic extract, with qualitative analysis confirming the presence of saponins, tannins, and flavonoids, suggesting a broader spectrum of bioactive compounds. The two bacterial supernatants were characterized by HPLC analysis and differed in their metabolic profiles: the Enterobacter sp. fermentation broth contained glycerol, 2,3-butanediol, and acetic acid, while the Paenibacillus sp. supernatant additionally contained lactic acid, ethanol, and succinic acid, reflecting distinct fermentation pathways. The in vitro and greenhouse studies aimed to evaluate biological preparations for controlling wheat diseases caused by fungi of the Fusarium genus as well as diseases affecting the stem base. Plant extracts (garlic—Allium sativum, Jerusalem artichoke—Helianthus tuberosus) and supernatants (fermentation broths) obtained with the Paenibacillus and Enterobacter bacteria were tested at three concentrations. In laboratory experiments, the degree of inhibition of the growth of the mycelium of the tested fungal species was determined, while in greenhouse studies, the effectiveness in limiting the development of stem base diseases and the impact of the applied biopreparations on plant growth were evaluated. Among the plant extracts, H. tuberosus demonstrated superior antifungal activity, achieving up to 100% inhibition of R. cerealis mycelial growth at 10% concentration and reducing disease severity by 34.3% compared to the untreated control under greenhouse conditions. Paenibacillus sp. supernatant demonstrated strong in vitro antifungal activity. The results indicate that H. tuberosus extract represents a promising candidate for further field evaluation as a component of sustainable wheat protection programs. Full article

Evidence suggests that a gluten-free diet may increase the risk of metabolic abnormalities associated with cardiovascular disease in adults with Coeliac Disease (CeD). This 9-week, double-blind, placebo-controlled, randomised pilot study investigated the effects of a combined supplement containing probiotic Lactiplantibacillus plantarum ECGC 13110402 and plant sterols and stanols, on cardiometabolic biomarkers and gut microbiota diversity and composition in adults with CeD and hypercholesterolaemia. Blood lipid profiles and vitamin D concentrations were analysed, and gut microbiota was profiled via 16S rRNA amplicon sequencing. In the active group, significant reductions in total cholesterol, LDL-cholesterol, non-HDL cholesterol, and apolipoprotein B were observed at multiple time points during the treatment phase, with changes generally greater in magnitude compared with the placebo group. Vitamin D levels also increased in the active group during supplementation. Microbiota analysis revealed potentially beneficial changes in participants receiving the active formulation, including higher alpha diversity and higher proportions of Bifidobacterium spp., Christensenellaceae R-7 group, and Lachnospiraceae ND3007 group. Overall, this feasibility study provides exploratory findings that a combined Lactiplantibacillus plantarum ECGC 13110402-phytosterol formulation may support lipid management and beneficially modulate gut microbiota in adults with CeD, particularly for those seeking non-pharmacological approaches to improving cardiometabolic health biomarkers. Full article

Tributyrin, a short-chain fatty acid derivative, has been shown to hold potential in improving intestinal health in livestock and poultry. However, its multidimensional effects on the health of meat pigeons, particularly during the young pigeon stage, remain unclear. This study aimed to investigate the comprehensive effects of dietary tributyrin supplementation on the growth, health status, intestinal function, and metabolic profile of young pigeons. A total of 100 healthy 29-day-old White King pigeons, with half male and half female, were randomly divided into a control group (fed a basal diet) and a treatment group (fed a basal diet supplemented with 1500 mg/kg tributyrin) for a 35-day trial. The results showed that compared with the control group, young pigeons in the treatment group had significantly reduced serum triglyceride levels, alanine aminotransferase activity, and concentrations of pro-inflammatory cytokines (TNF-α, IL-6), along with significantly increased levels of high-density lipoprotein, immunoglobulin G, total antioxidant capacity, and glutathione peroxidase activity. Concurrently, the villus height-to-crypt depth ratio in the jejunum and ileum was significantly elevated, indicating improved intestinal morphological structure. Untargeted metabolomics analysis further revealed significant changes in the relative abundances of 13 key differential metabolites (e.g., L-carnitine, pyridoxamine, indoleacetic acid) in the small intestinal contents of the treatment group. These metabolites were mainly enriched in metabolic pathways such as 2-oxoCarboxylic acid metabolism, tryptophan metabolism, and vitamin B6 metabolism. In conclusion, dietary supplementation with 1500 mg/kg tributyrin can exert multifaceted beneficial effects on young pigeon health by improving lipid metabolism, enhancing immune and antioxidant functions, optimizing intestinal structure, and regulating the local metabolic network. This study provides a theoretical basis for the application of tributyrin as a functional additive in the green and healthy production of meat pigeons. Full article

Vitamin B₁₂ supplementation among people without proven deficiency has become popularized, driven by perceptions of (i) frequent underdiagnosis of deficiency, (ii) promotion as a natural enhancer of well-being, and (iii) a favourable safety profile. Here, we examine whether these claims align with current evidence. We present guidance from major health authorities, which advises against routine testing in asymptomatic individuals without risk factors. The prevalence of B₁₂ deficiency varies greatly, mainly because definitions of B₁₂ deficiency are not standardized and may include clinical, biochemical, or functional criteria. Biochemical deficiency (typically serum B₁₂ < 148 pmol/L) is the predominant definition in epidemiological and clinical research studies. Using this criterion, deficiency appears uncommon in general populations of high-income countries (~2%), but substantially more frequent in settings with limited access to animal-source foods or B₁₂-fortified products (up to 69%). Studying the effects of supplementation is also challenged by variation in the regimens used, which range from 0.02 to 1 mg/day orally and from 1 to 5 mg/week intramuscularly, with durations spanning ~4 weeks to ~7 years. This limits cross-study comparability. Overall, supplementation has not shown consistent benefits in populations without overt clinical or biochemical B₁₂ deficiency, with no clear improvements in fatigue, mood, cognition, or cardiovascular outcomes. Benefits, when reported, appear confined to selected subgroups (e.g., hyperhomocysteinemia or low–normal B₁₂ status). B₁₂ supplementation is generally well tolerated. There are rare reports of acneiform and hypersensitivity responses, although these cannot be completely distinguished from reactions to, e.g., excipients. Observational studies associate B₁₂ supplementation and higher circulating B₁₂ levels with increased risks of malignancy. However, these findings are inconsistent, and current evidence is insufficient to establish causality, as potential reverse causation remains a major concern. Full article

Background/Objectives: The vitamin B12 (VB12)/C-reactive protein (CRP) index (BCI), a clinically derived index calculated as serum VB12 multiplied by CRP, has shown prognostic value in several cancers. However, its association with survival outcomes in metastatic renal cell carcinoma (mRCC) remains unclear. Therefore, the aim of the present study was to evaluate the prognostic significance of BCI in patients with mRCC treated with targeted therapy. Methods: The BCI was calculated as serum VB12 concentration (pg/mL) × serum CRP concentration (mg/L). The patients were categorized into two BCI prognostic subgroups, high BCI (BCI > 40,000) and low BCI (≤40,000). Survival differences between prognostic subgroups were measured using the Kaplan–Meier method with a log-rank test. Univariate and multivariable analyses were used to determine the association between the selected variables and survival outcomes. Results: We included 213 patients with mRCC, with a median follow-up time of 76 months. The median progression-free survival (PFS) and overall survival (OS) were 10.9 months and 47.7 months, respectively. Patients with high BCI had poorer PFS and OS times than those with low BCI (7.8 months vs. 12.6 months, p = 0.002 for PFS; 22.6 months vs. 68 months, p < 0.001 for OS, respectively). After adjusting for potential confounders, high BCI remained independently associated with poorer PFS and OS (hazard ratio [HR]: 2.40, 95% confidence interval [CI] 1.35–4.26, p = 0.003 for PFS; HR 2.01, 95% CI 1.40–2.88, p < 0.001 for OS). Conclusions: BCI appears to be a promising prognostic biomarker in patients with mRCC treated with first-line targeted therapy. However, its applicability to immune checkpoint inhibitor-based or combination regimens requires prospective validation. Full article

Neural tube defects (NTD) are congenital malformations that lead to structural abnormalities of the brain or spine. Mouse embryos deficient in Scavenger Receptor Class B Type 1 (SR-B1 KO), the main receptor for high-density lipoproteins, exhibit a high incidence of anterior NTD, which is associated with vitamin E deficiency and elevated levels of reactive oxygen species (ROS). Maternal supplementation with vitamin E, a micronutrient with antioxidant properties, completely prevents the occurrence of NTD and normalizes ROS levels in SR-B1 KO embryos, suggesting a contribution of oxidative stress to NTD in this model. In this work, we showed that SR-B1 KO embryos at gestational day E9.5 display higher levels of lipoperoxidative damage markers. Analysis of data obtained through shotgun lipidomics evidenced a selective and coordinated reorganization of fatty acid distribution, characterized by altered polyunsaturated and monounsaturated composition, together with reduced phosphatidylcholine and increased lysophosphatidylcholine levels, and diversion of fatty acids into triacylglyceride storage. Transcriptomic analysis revealed a coordinated upregulation of genes involved in phospholipid synthesis and remodeling, consistent with the altered lipid homeostasis observed in SR-B1 KO embryos. Together, these results provide novel information showing a potential link between oxidative stress and disruptions in mammalian embryonic lipid metabolism, highlighting phospholipid remodeling as a potential determinant of susceptibility to NTD. Full article

Polycyclic aromatic hydrocarbons (PAHs) are common environmental contaminants formed during the incomplete combustion of organic material. Their persistence, bioaccumulation, and metabolic activation contribute to mutagenic and cytotoxic outcomes. Among these are benzo[a]pyrene (B[a]P), the most studied PAH and a benchmark compound for PAH carcinogenicity, and pyrene, a PAH whose urinary metabolite 1-hydroxypyrene is widely used as a biomarker of PAH exposure. B[a]P undergoes CYP1A1-mediated oxidation to generate reactive oxygen species (ROS) via epoxide and quinone redox cycling, whereas pyrene produces ROS primarily through pyrene-quinone redox cycling. We investigated cobinamide, a vitamin B₁₂/cobalamin analog with potent antioxidant properties, for mitigating benzo[a]pyrene- and pyrene-induced injury. In H9C2 rat embryonic cardiomyoblasts and A549 human lung epithelial cells exposed to B[a]P (10 μM) or pyrene (10–100 μM), cobinamide (5–10 μM) attenuated PAH-induced reductions in cell number in both models, while in H9C2 cells, it also attenuated decreases in metabolic activity and reduced apoptosis. Cobinamide also returned JNK/p38 phosphorylation to near baseline levels, decreased DNA and protein oxidation and DNA strand breaks. Transcriptionally, cobinamide suppressed inflammatory (TNF-α, IL-1β, and IL-6) and oxidative stress genes (HMOX1 and NOX4), while enhancing oxidative response (SOD2) and xenobiotic metabolism (CYP1A1). In Drosophila melanogaster exposed to 5 mM B[a]P/pyrene, 2 mM cobinamide improved survival and fully restored locomotion, outperforming cobalamin (minimal benefit) and N-acetylcysteine (partial rescue). Spectroscopic analyses showed no direct cobinamide-PAH binding. These findings demonstrate that cobinamide efficiently limits ROS-mediated PAH injury through redox modulation while preserving xenobiotic metabolism, suggesting its potential therapeutic use to mitigate PAH-induced toxicity. Full article

Background and Clinical Significance: Vitamin B12 deficiency in infancy is an uncommon but reversible cause of severe hematologic abnormalities and potential neurologic injury, particularly in exclusively breastfed infants whose vitamin B12 status depends on maternal stores. Because its clinical presentation may mimic bone marrow failure syndromes or hematologic malignancies, diagnosis can be challenging and delayed; Case Presentation: We report a case of early infantile pancytopenia ultimately attributed to profound vitamin B12 deficiency secondary to maternal celiac disease. Prompt recognition and treatment with cobalamin supplementation resulted in rapid hematologic recovery and a favorable clinical outcome; Conclusions: This case underscores the importance of considering vitamin B12 deficiency in the differential diagnosis of unexplained cytopenias in infants and highlights the critical role of maternal nutritional status in neonatal health. Improved awareness and targeted screening of at-risk mothers during pregnancy and lactation may prevent severe but readily treatable complications in affected infants. Full article

TANGO2-deficiency disorder (TDD) is a rare autosomal recessive condition characterised by neurodevelopmental delay, TANGO2 spells, life-threatening metabolic crises, and cardiac arrhythmias. Genotype–phenotype correlations remain poorly defined and the neurobehavioural profile of affected individuals is largely unexplored. We conducted a retrospective multicentre study of five Italian patients with genetically confirmed TDD, identified between June 2023 and May 2025. Clinical, neurophysiological, neuroimaging, genetic, and neurodevelopmental data were collected. Adaptive functioning, cognitive ability, and behavioural profiles were assessed using standardised instruments. All five patients carried biallelic TANGO2 mutations, including two previously unreported variants. Clinical severity ranged from an asymptomatic individual under preventive therapy to a fatal early-onset metabolic crisis. Marked intrafamilial variability was observed in two siblings sharing the same genotype. Systematic neurodevelopmental assessment revealed a spectrum of cognitive and adaptive outcomes, with attentional difficulties identified as a recurrent feature. No metabolic crises or TANGO2 spells were documented following initiation of B-vitamin and cofactor supplementation in surviving patients. This cohort expands the mutational and phenotypic spectrum of TDD and highlights the diagnostic value of TANGO2 testing in patients with neurodevelopmental delay or paroxysmal neurological episodes, even in the absence of metabolic crises. Early supplementation therapy may contribute to clinical stability, though prospective controlled studies are needed. Full article

Aim: To assess abnormalities in red blood cell parameters, iron metabolism, and vitamin B12 status in children with obesity, and to evaluate the influence of dietary intake and obesity-related complications on these variables. Methods: A retrospective analysis was conducted in 152 children with obesity. Anthropometric, biochemical, and hematological parameters were assessed. Dietary intake was evaluated in a subgroup of 33 participants using 3-day food records. Results: No cases of low hemoglobin levels were identified. However, elevated TIBC and occasional low ferritin levels suggested disturbances in iron metabolism. BMI Z-score was positively associated with red blood cell count and selected iron metabolism markers, whereas higher body fat percentage was negatively associated with hemoglobin and hematocrit. Dietary analysis indicated that protein and vitamin B12 intake were associated with erythrocyte parameters, while no associations were found for iron or folate intake. Elevated liver enzymes were associated with higher hemoglobin, hematocrit, and MCV values. Conclusions: Pediatric obesity was not associated with low hemoglobin levels but may be linked to early, subclinical disturbances in iron metabolism. These findings should be confirmed using more comprehensive biomarkers. Dietary factors, particularly vitamin B12 intake, may contribute to variability in erythrocyte parameters; however, these associations should be interpreted with caution. The observed relationship between liver function and erythrocyte indices warrants further investigation. Full article